CRNX
Price:
$56.825
Market Cap:
$5.12B
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsu...[Read more]
Industry
Biotechnology
IPO Date
2018-07-18
Stock Exchange
NASDAQ
Ticker
CRNX
According to Crinetics Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.87B. This represents a change of 87.28% compared to the average of 2.60B of the last 4 quarters.
The mean historical Enterprise Value of Crinetics Pharmaceuticals, Inc. over the last ten years is 720.37M. The current 4.87B Enterprise Value has changed 67.47% with respect to the historical average. Over the past ten years (40 quarters), CRNX's Enterprise Value was at its highest in in the June 2024 quarter at 3.39B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.
Average
720.37M
Median
455.81M
Minimum
319.17M
Maximum
2.06B
Discovering the peaks and valleys of Crinetics Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.62%
Maximum Annual Enterprise Value = 2.06B
Minimum Annual Increase = -40.37%
Minimum Annual Enterprise Value = 319.17M
Year | Enterprise Value | Change |
---|---|---|
2023 | 2.06B | 124.09% |
2022 | 920.62M | 2.94% |
2021 | 894.35M | 162.62% |
2020 | 340.55M | -40.37% |
2019 | 571.07M | 78.93% |
2018 | 319.17M | -2.08% |
2017 | 325.96M | -0.69% |
The current Enterprise Value of Crinetics Pharmaceuticals, Inc. (CRNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.29B
5-year avg
957.92M
10-year avg
720.37M
Crinetics Pharmaceuticals, Inc.’s Enterprise Value is greater than Viridian Therapeutics, Inc. (1.65B), less than Cytokinetics, Incorporated (6.65B), greater than Structure Therapeutics Inc. (1.91B), greater than Icosavax, Inc. (713.87M), less than Passage Bio, Inc. (0), greater than REGENXBIO Inc. (38.44M), greater than LianBio (534.64M), greater than Kezar Life Sciences, Inc. (-66141903.00), greater than Inhibrx Biosciences, Inc. (41.43M), greater than Merus N.V. (-602006.00), greater than Lyell Immunopharma, Inc. (3.09B), greater than Kronos Bio, Inc. (251.92M), greater than Black Diamond Therapeutics, Inc. (14.20M), greater than TCR2 Therapeutics Inc. (159.92M), greater than Harpoon Therapeutics, Inc. (49.64M), greater than Alector, Inc. (861.85M), greater than null (503.40M),
Company | Enterprise Value | Market cap |
---|---|---|
1.65B | $1.74B | |
6.65B | $6.05B | |
1.91B | $2.28B | |
713.87M | $769.04M | |
0 | $37.06M | |
38.44M | $433.69M | |
534.64M | $34.47M | |
-66141903.00 | $52.10M | |
41.43M | $224.09M | |
-602006.00 | $3.52B | |
3.09B | $325.12M | |
251.92M | $57.28M | |
14.20M | $168.95M | |
159.92M | $58.11M | |
49.64M | $865.08M | |
861.85M | $514.83M | |
503.40M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crinetics Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Crinetics Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Crinetics Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Crinetics Pharmaceuticals, Inc. (CRNX)?
What is the 3-year average Enterprise Value for Crinetics Pharmaceuticals, Inc. (CRNX)?
What is the 5-year average Enterprise Value for Crinetics Pharmaceuticals, Inc. (CRNX)?
How does the current Enterprise Value for Crinetics Pharmaceuticals, Inc. (CRNX) compare to its historical average?